title: Durable complete remission of primary plasma cell leukemia with the bortezomib plus melphalan and prednisone (VMP) regimen.
authors.forename: Edward
authors.initials: E
authors.lastname: Libby
authors.forename: Dulcinea
authors.initials: D
authors.lastname: Candelaria-Quintana
authors.forename: Hayan
authors.initials: H
authors.lastname: Moualla
authors.forename: Maryam
authors.initials: M
authors.lastname: Abdul-Jaleel
authors.forename: Ian
authors.initials: I
authors.lastname: Rabinowitz
mesh_terms: D000369:Aged, 80 and over; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage*; D001897:Boronic Acids / Q000008:administration & dosage; D000069286:Bortezomib; D005260:Female; D006801:Humans; D007952:Leukemia, Plasma Cell / Q000188:drug therapy*; D008558:Melphalan / Q000008:administration & dosage; D011239:Prednisolone / Q000008:administration & dosage; D011719:Pyrazines / Q000008:administration & dosage; D012074:Remission Induction
chemical_list: D001897:Boronic Acids; D011719:Pyrazines; D000069286:Bortezomib; D011239:Prednisolone; D008558:Melphalan